Utah Medical Products (UTMD) Depreciation & Amortization (CF) (2010 - 2026)
Utah Medical Products (UTMD) recorded quarterly Depreciation & Amortization (CF) of $211000.0 in Q1 2026, little changed quarter-over-quarter from $212000.0 in Q4 2025, and up 5.5% on a YoY basis from $200000.0 in Q1 2025.
Utah Medical Products (UTMD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Utah Medical Products' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $211000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 5.5% year-over-year to $211000.0; the TTM figure through Mar 2026 stood at $837000.0 (up 8.14% YoY), while the FY2025 annual figure was $826000.0, up 13.15% from the prior year.
- Depreciation & Amortization (CF) was $211000.0 for Q1 2026 at Utah Medical Products, roughly flat from $212000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $212000.0 in Q4 2025 to a low of $149000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $176588.2 across 5 years, with a median of $158000.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) declined 8.59% in 2022, then jumped 30.97% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $158000.0 in 2022, then changed by 0.0% to $158000.0 in 2023, then grew by 26.58% to $200000.0 in 2024, then grew by 6.0% to $212000.0 in 2025, then fell by 0.47% to $211000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $211000.0 (Q1 2026), $212000.0 (Q4 2025), and $209000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Utah Medical Products | 216.87 Mn | 129.46 Mn | 5.28 Mn | 211,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211,000.00 |
| Mar 31, 2026 | 211,000.00 |
| Dec 31, 2025 | 212,000.00 |
| Dec 31, 2025 | 212,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 158,000.00 |
| Dec 31, 2023 | 158,000.00 |